Tag:
Riata
Latest Headlines
Latest Headlines
St. Jude armed with FDA approval for Ellipse ICD
The Minnesota device company stalwart has gained FDA approval for its new Ellipse implantable cardioverter defibrillator (ICD), a tiny device shaped by input from 200 physicians who carved their vision in clay.
St. Jude touts safety of leads with Optim insulation
St. Jude Medical ($STJ) is touting the safety and reliability of its Durata leads with Optim insulation in its biannual report on the performance of its cardiac rhythm management devices.
Boston Sci heart device malfunction led to patient death
Boston Scientific ($BSX) is experiencing its own problems after the relevation of a flaw in its Cognis and Teligen defibrillators.
St. Jude, Medtronic gave cash to controversial author's institute
It turns out that St. Jude Medical ($STJ) and Medtronic ($MDT) have both given substantial donations to Dr. Robert Hauser's Minneapolis Heart Institute Foundation, according to a juicy new report in MedCity News.
What can St. Jude expect post-Riata?
How concerned is Wall Street about St Jude Medical's ($STJ) heart rhythm devices? Very, especially since physicians might now think twice about using the company's devices.
Tough luck, St. Jude: No retraction for you
If St. Jude Medical had hopes that HeartRhythm would retract a controversial study regarding its Riata defibrillator wires, the editor-in-chief dashed them Tuesday afternoon.
UPDATED: Medtronic backs Hauser's findings on Riata leads
St. Jude Medical ($STJ) might not like one researcher's claims that its Riata and Riata ST defibrillator leads were not up to snuff and led to patient deaths, but Medtronic ($MDT) isn't complaining about his results.
St. Jude demands retraction of Riata lead study
St. Jude Medical ($STJ) is fighting back after some bad publicity over faulty leads. The company's first target: Dr. Robert Hauser of the Minneapolis Heart Institute.
Study: Riata wires have additional risky defects
There may be more risky defects with St. Jude Medical's recalled Riata wires, which are still in roughly 79,000 patients, that have led to electrical abnormalities and multiple conductors.
Doctors in limbo over recalled St. Jude defib lead
About 76,000 people implanted with St. Jude Medical's Riata defibrillator lead remain in limbo, three months after the FDA recalled the wire over electrical failure-related safety concerns. That's because recalls can't take back implants already inside patients.
